News

March 27, 2020March 27, 2020

Mix of Broad and Specific Language May Help in Talking About MS

News

Using a mix of broad diagnostic terms and more disease-specific ones may help physicians and patients to better communicate symptoms of autoimmune disorders like multiple sclerosis (MS) that are not always ... Read more

March 27, 2020March 27, 2020

Potential Competitor to Acthar Gel Asking to Re-enter US Market

News

ANI Pharmaceuticals is asking the U.S. Food and Drug Administration (FDA) for the right to reintroduce in the U.S. market its Cortrophin Gel (repository corticotropin injection, 80 U/ml) to ... Read more

March 26, 2020March 26, 2020

Helius Medical Technologies Authorized by Heath Canada to Market PoNS Device

News

The neurotechnology company Helius Medical Technologies has received authorization from Health Canada to market its portable neuromodulation stimulator (PoNS) device to treat gait deficit in patients with mild-to-moderate multiple sclerosis (MS). ... Read more

March 26, 2020March 27, 2020

FDA Approves Zeposia (Ozanimod), Oral Therapy for All with Relapsing MS

News, SPMS

The U.S. Food and Drug Administration (FDA) has approved Zeposia (ozanimod) oral capsules to treat adults with relapsing forms of multiple sclerosis (MS), including relapsing-remitting MS (RRMS),  active secondary progressive MS (SPMS), and ... Read more

March 25, 2020March 25, 2020

Myelin Health Depends on Steady Supply of Lipids, Study Suggests

News

Continuous production of fatty molecules (lipids) is crucial to the maintenance of the myelin sheath that wraps nerve fibers to protect them, ensuring the transmission of electrical impulses between ... Read more

March 25, 2020March 25, 2020

‘Talk’ Therapy Helps with Insomnia and Fatigue in MS, Trial Suggests

News

Cognitive behavioral therapy, a type of “talk” therapy, may help ease the severity of insomnia, fatigue, and anxiety in people with multiple sclerosis (MS), improving the quality of their ... Read more

March 24, 2020March 24, 2020

Risk of Faster Progression in PPMS Tied to Older Age and Active Disease

News

Older age at onset and evidence of active disease, like clinical relapses or inflammatory brain lesions, significantly increase the likelihood of  faster disability progression in primary progressive multiple sclerosis ... Read more

March 24, 2020March 24, 2020

ImStem Biotechnology to Launch Phase 1 Trial Testing IMS001 for MS

News

The U.S. Food and Drug Administration (FDA) has lifted the clinical hold and cleared the investigational new drug (IND) application to assess IMS001 in the treatment of multiple sclerosis ... Read more

March 23, 2020March 23, 2020

Phase 2 Trial of Progressive MS Treatment Postponed Due to COVID-19

News

A planned Phase 2 clinical trial of a potential treatment for progressive multiple sclerosis has been postponed to keep hospital resources open to treat people with COVID-19 during the ongoing ... Read more

March 23, 2020March 23, 2020

Cognitive Impairment in Early MS Not Linked to Ethnicity, US Study Suggests

News

Ethnicity does not seem to have an influence on the degree of cognitive impairment seen in patients at the early stages of multiple sclerosis (MS), a U.S.-based study suggests. ... Read more

March 20, 2020March 24, 2020

Janssen Seeks FDA Approval for Oral Ponesimod for Treating Relapsing MS

News

Janssen has submitted an application to the U.S. Food and Drug Administration (FDA) asking for ponesimod to be approved as an oral treatment for adults with relapsing multiple sclerosis (MS). Ponesimod, ... Read more

March 20, 2020March 23, 2020

Gilenya Outperforms Avonex in Lessening Brain Lesion Activity, Atrophy in Children with MS, Trial Shows

News

Oral treatment with Gilenya (fingolimod) is more effective than Avonex (interferon beta-1a) for controlling brain lesion activity and brain volume loss in children with pediatric-onset multiple sclerosis (POMS), two-year results ... Read more

March 19, 2020March 19, 2020

Canadian Study Reports Fewer MS-related Hospital Admissions as Patients Age and Among Women

News

Older age, a greater number of health conditions, and prior hospital admissions are associated with more hospitalizations due to all causes among people with multiple sclerosis (MS). However, MS-related ... Read more

March 19, 2020March 19, 2020

More Attention Should Be Given to MS Patients’ Sexual Dysfunction, Study Advises

News

Sexual dysfunction is prevalent among women with multiple sclerosis (MS), and one way physicians can help improve their patients’ quality of life is to ask them about the problem. ... Read more

March 18, 2020March 18, 2020

MS Patients Find Cannabis Helpful for Easing Pain, Spasticity, Study Reports

News

About 85% of people with multiple sclerosis (MS) using cannabis find it to be helpful for pain, and 79% find it eases spasticity, a new study reports. The study, “Cannabis ... Read more

March 18, 2020March 18, 2020

Gilenya Linked to Slightly Increased Cancer Risk in MS, Swedish Study Suggests

News

The risk of invasive cancer may be slightly higher in multiple sclerosis (MS) patients treated with Gilenya (fingolimod) compared with those treated with rituximab, and with people from the general ... Read more

March 17, 2020March 17, 2020

Virtual Reality Test Can Detect Subtle Balance Issues in MS Patients

News

A new test involving a virtual reality simulation was able to detect balance issues in patients with multiple sclerosis (MS), potentially allowing doctors to identify whether a patient is ... Read more

March 17, 2020March 17, 2020

TV Personality Montel Williams Launches ‘My MS: Second Act’

News

A little over 20 years ago, Montel Williams learned once and for all that he had multiple sclerosis (MS). But that determination should have happened long before then, said ... Read more

March 16, 2020March 20, 2020

#ACTRIMS2020 – CNM-Au8 a Potential ‘Breakthrough’ in MS Therapy, Clene CMO Says

News

An investigational therapy that uses nanocrystals of gold to help the brain repair itself represents a breakthrough in the multiple sclerosis (MS) field, says Clene Nanomedicine‘s chief medical officer ... Read more

March 16, 2020March 16, 2020

Metabolite of Gut Bacteria, as Supplement, May Regulate Immune System

News

A short-chain fatty acid produced by gut bacteria helps to counteract inflammatory responses in multiple sclerosis (MS) by promoting greater numbers of regulatory immune cells, a study reports. But ... Read more

March 13, 2020March 13, 2020

#ACTRIMS2020 – Ofatumumab Self-injection Pen May Be ‘Very Attractive’ Option for Relapsing MS

News

Monthly under-the-skin injections of Novartis’ investigational candidate ofatumumab show promise as a convenient, effective, and safe therapeutic option for people with relapsing multiple sclerosis (MS). Data from the ASCLEPIOS and APLIOS ... Read more

March 13, 2020March 13, 2020

Second Phase 3 Trial of MedDay’s MD1003 for Progressive MS Fails to Meet Goals

News

MedDay Pharmaceuticals‘ MD1003 did not ease functional disability or its progression in patients with non-active progressive multiple sclerosis, Phase 3 clinical trial data shows. The SPI2 Phase 3 study (NCT02936037) ... Read more

March 12, 2020March 12, 2020

THC:CBD Oral Spray Sativex Provides Consistent Relief for Treatment-resistant MS Spasticity

News

Sativex (nabiximols), a THC:CBD oral spray, consistently relieves the pain and severity of treatment-resistant spasticity in multiple sclerosis (MS) patients, according to a recent study. An analysis of the Sativex as ... Read more

March 12, 2020March 13, 2020

Ponesimod, Up for Approval, Shows ‘Clear Superiority’ Over Aubagio, Janssen Exec Says

News

Ponesimod may soon be a new oral therapy for people with relapsing multiple sclerosis (MS) in Europe, and a filing for its approval in the U.S. is likely within weeks. ... Read more

March 11, 2020March 12, 2020

Blood NfL Potential Marker of MS Therapies’ Effectiveness, Study Suggests

News

Starting treatment with a disease-modifying therapy (DMT) reduces blood levels of neurofilament light chain (NfL) — a potential biomarker of disease progression and activity — to varying degrees depending on ... Read more

March 11, 2020March 11, 2020

MSAA Events Focus on Mind-Body Connection to Mark MS Awareness Month

News

The Multiple Sclerosis Association of America (MSAA) is offering a host of educational activities on wellness strategies that address both the mind and body in its efforts to mark ... Read more

March 10, 2020March 10, 2020

Researchers Study Cognitive Decline in Older MS Patients for Alzheimer’s Link

News

As multiple sclerosis (MS) patients live longer, researchers have observed similarities between changes in their brains and in the brains of Alzheimer‘s patients, a study found. Understanding whether these ... Read more

March 9, 2020March 9, 2020

Final Site Announced in Phase 2 Trial Testing NurOwn in Progressive MS

News

The Partners Multiple Sclerosis Center at Brigham and Women’s Hospital has joined BrainStorm Cell Therapeutics in a Phase 2 trial exploring the safety and efficacy of NurOwn in the ... Read more

March 9, 2020March 9, 2020

Myo Wearable Sensor Captures Subtle Movement Problems in MS

News

An multi-sensor band worn on the arm or leg, called Myo, can capture and relay difficulties with limb movement due to multiple sclerosis (MS) with an accuracy that mirrors ... Read more

March 6, 2020March 6, 2020

Health Canada Approves Mayzent to Treat Active SPMS

News

Health Canada has approved Novartis‘s Mayzent (siponimod) for the treatment of adults with active secondary progressive multiple sclerosis (SPMS) to delay the progression of physical disability. Active disease is determined either by the presence ... Read more

March 6, 2020March 11, 2020

#ACTRIMS2020 – What We Now Know About Diet and MS

News

What science has told us about how diet might influence a person’s risk of multiple sclerosis and a patient’s disease course was the topic of discussion at a recent MS ... Read more

March 5, 2020March 16, 2020

MS Society Spotlights Patient Stories for MS Awareness Week, March 8-14

News

The National Multiple Sclerosis Society (NMSS) is marking Multiple Sclerosis Awareness Week, March 8-14, by sharing patients’ stories and encouraging participation in fundraising and advocacy efforts. Each year, a week is ... Read more

March 5, 2020March 5, 2020

Janssen Asks EMA to Approve Oral Ponesimod to Treat Relapsing MS

News

Janssen has submitted an application to the European Medicines Agency (EMA) asking that ponesimod be approved as an oral treatment for adults with relapsing multiple sclerosis (MS) in the European Union. Ponesimod ... Read more

March 4, 2020March 4, 2020

Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare

News

In recognition of Rare Disease Day Feb. 29, BioNews Services launched a social media campaign last month asking patients to describe what makes them rare. Running Feb. 7–29, the ... Read more

March 4, 2020March 4, 2020

Natural Molecule NAC May Help Improve MS Brain Function, Study Reports

News

Treatment for two months with N-acetylcysteine, or NAC — a natural molecule that enhances the levels of antioxidants — significantly improved metabolic activity in certain brain regions among people ... Read more

March 4, 2020March 24, 2020

#ACTRIMS2020 – 3 Ways to Treat MS by Altering Gut Microbiome Under Study

News

Modulating the bacteria that reside in the gut by treating multiple sclerosis (MS) patients with probiotics, fecal transplants, or gut-related microRNAs may help to ease inflammation and disease severity, researchers with Brigham ... Read more

March 3, 2020March 3, 2020

#ACTRIMS2020 – IL-13 May Be ‘Attractive’ Target for Easing Inflammation in MS

News

A signaling molecule of the immune system called interleukin 13 (IL-13) may modulate the function of key immune cells involved in multiple sclerosis (MS), and their migration through the ... Read more

March 3, 2020March 3, 2020

#ACTRIMS2020 – EHP-101 Shows Promise in Early Studies; Phase 2 Trial Ahead

News

Emerald Health Pharmaceuticals’ investigational cannabidiol-derived EHP-101 continues to show potential to ease inflammation and myelin loss (demyelination) — a hallmark of multiple sclerosis (MS) — according to data from ... Read more

March 3, 2020March 3, 2020

#ACTRIMS2020 – Ozanimod May Ease Inflammation While Retaining Some Immune Defenses

News

Ozanimod — an investigational oral therapy up for approval to treat relapsing multiple sclerosis (MS) — lowers the number of white blood cells circulating in the blood, supporting its ... Read more

March 2, 2020March 5, 2020

#ACTRIMS2020 – CorTechs Says AI Models May Improve Early MS Diagnosis

News

CorTechs Labs presented new data indicating that machine learning models based on magnetic resonance imaging (MRI) of the brain may aid in the early diagnosis of multiple sclerosis (MS). ... Read more